BioSig (BSGM) Announces First Sale of Pure EP Systems

BioSig (BSGM) Announces First Sale of Pure EP Systems

Good day everyone,

This week’s feature coverage BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace.

Current price $4.48 per share
Outstanding shares (est.) 30.7M
Shares in float (est.) 23.5M
Insider ownership 22%
Institutional ownership 18.4%
52-week high $12.43/share

BSGM shares have been trending in the new year. At the beginning of last week, the company’s shares opened at $3.90 and in the ensuing five trading sessions gained 16%. As the chart indicates BSGM shares have broken through their 50 DMA of $4.15/share. The SMA20 and SMA50 are both green.

We believe that BSGM has the potential for a breakout in the near term. The current share price is 63% off the 52-week high and is substantially off the recent high of $9.00/share reached on September 18, 2020. The trend in BSGM shares may be fueled by recent developments and milestones at the company as we describe below.

Those who have followed BSGM for a while have now seen a milestone long awaited. The first commercial sale of their PURE EP System.

Last week, St. David’s HealthCare of Austin, Texas, purchased three PURE EP™ Systems, marking the company’s first commercial sale and a critical milestone to expand its clinical footprint nationwide.

“This installation cements our valued relationship with St. David’s and adds to the traction we are gaining in the electrophysiology (EP) market,” said Kenneth L. Londoner, Chairman & CEO of BioSig Technologies, Inc.

The significance of the first commercial sale of the PURE EP™ Systems underscores the quality and benefit of the technology. In the biotech sector we follow many developmental companies waiting for the day when their product(s) come to market. BSGM has reached that milestone.

The company’s NeuroClear Technologies division signed a new research agreement with the University of Minnesota.

Under the terms of the agreement, the Company intends to launch a program to develop novel therapies to treat sympathetic nervous system disease. NeuroClear intends to develop hardware, software, and algorithmic solutions, developed under the new agreement, in partnership with a tier 1 US-based manufacturing partner and take it through FDA approval, manufacturing, and commercialization.

BSGM has a high level of insider ownership. Insiders continue to buy up the company shares and there have been zero insider sales in the past year. In December, CEO Kenneth Londoner bought 2,000 shares at an average price of $4.65. After the transaction, his stake in BioSig Technologies Inc. moved to 1,345,558 shares.

Institutional investment is also high at BSGM at 18% with most of those shares being held by Blackrock and Vanguard Funds. Institutions always hold some shares in developmental companies, but a level of 18% may indicate confidence in the BSGM technology and/or their management team.

Why BSGM shares may see a near term breakout
Low float can make the share price move quickly.
Revenues, first major product sales can quickly lead to more.
63% off 52-week high and 51% off their September high.
New agreements and partners at NeuroClear.

The events happening at BSGM, right now, could drive the price much higher in the near term.

Stay tuned for our full report on BSGM tomorrow when we look at the potential market for the PURE EP™ System and who their competitors might be.

The Traders News Group

Privacy Policy and Disclaimer
Your Consent
By using our site, you consent to our online privacy policy and disclaimer.
Do we disclose any information to outside parties?
We do not sell your information to anyone. Please see our cookie policy below.
What information do we collect?
We collect information from you when you subscribe to our newsletter or fill out a form on one of our social platforms. This includes your email address and or mobile phone number.
When registering on our site, as appropriate, you may be asked to enter your: e-mail address and or mobile number.
What do we use your information for?
When we collect your email or mobile number it is used for one purpose to send you the information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.
Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.
We send periodic emails
The email address you provide may be used to send you information, the small cap stock reports you requested, respond to inquiries, and/or other requests or questions.
How do we protect your information?
We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use secure third parties to send email and sms messages to you.
Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act.
Online Privacy Policy Policy
This online privacy policy applies to information collected through our website and social media platforms.
Contacting Us
If there are any questions regarding this privacy policy or disclaimer you may contact us using the information below.
Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.

Please Note: TNS LLC and its employees are not a registered investment advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. TNS LLC’s sister company (SCS LLC) has been compensated twenty one thousand five hundred dollars cash via bank wire by legends media llc for this week’s coverage of bsgm The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.
TNS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. TNS LLC is not a Broker/Dealer and does not engage in high frequency trading.